Latest Publications

Share:

COVID-19 Vaccinations and Considerations for European Employers

The Situation: With COVID-19 vaccination campaigns underway throughout Europe, employers are now evaluating how the availability of vaccines may impact their own workforce, including whether they can make vaccination...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 38

LATEST KEY DEVELOPMENTS - Competition & State Aid • Use of EU COVID-19 recovery funds to roll out very high capacity telecoms networks must adhere to State aid rules • EU approves new and amended Member State measures to...more

Health Care Organizations and Cloud Service Providers Receive Guidance on Cloud Security Measures

The Situation: The health care sector is currently going through a digital transformation phase with the promise of achieving improved patient care and higher efficiency—and the implementation of cloud-based services is a...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 37

LATEST KEY DEVELOPMENTS - Competition & State Aid • European Commission launches public consultation on revision of IPCEI Communication • EU approves new and amended Member State measures to support the...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 36

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS -...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 35

Competition & State Aid • EU approves new and amended Member State measures to support the economy Trade / Export Controls • EU and India launch the High-Level Dialogue on Trade and Investment, with a particular...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 34

LATEST KEY DEVELOPMENTS Competition & State Aid • European Commission prolongs and further expands Temporary Framework to support economy in context of coronavirus outbreak • EU approves new and amended Member...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 32

LATEST KEY DEVELOPMENTS - Competition & State Aid • European Commission launches public consultation on fair taxation in the digital economy • European Commission proposes to further prolong and adjust State aid...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 33

LATEST KEY DEVELOPMENTS Competition & State Aid • EU approves new and amended Member State measures to support the economy Trade / Export Controls • European Commission announces export transparency mechanism...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 31

LATEST KEY DEVELOPMENTS - Competition & State Aid • €25 billion Pan-European Guarantee Fund deployed for the first time • EU approves new and amended Member State measures to support the economy Trade / Export...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 30

LATEST KEY DEVELOPMENTS - Competition & State Aid • European Commission addresses State aid support in Communication on tackling nonperforming loans in the aftermath of COVID-19 pandemic • European Commission...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 29

This regular update (no. 29 | 15 December 2020) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 28

LATEST KEY DEVELOPMENTS - Competition & State Aid • EU approves new and amended Member State measures to support the economy • Executive Vice-President and Competition Commissioner Vestager speech on the future of State...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 27

LATEST KEY DEVELOPMENTS - Competition & State Aid • EU approves new and amended Member State measures to support the economy • European Commission Executive Vice-President Margrethe Vestager speech on COVID-19 State...more

New Guidance: Inside Information Disclosure by Listed Biotech Companies in Belgium

The Development: Belgium's financial regulator, the Financial Services and Markets Authority ("FSMA"), published a recent opinion on "Considerations and good practices with respect to inside information disclosures by listed...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 26

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 24

This regular update (no. 24 | 13 October 2020) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 25

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. LATEST KEY DEVELOPMENTS...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 23

This regular update (no. 23 | 29 September 2020) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 22

This regular update (no. 22 | 22 September 2020) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal...more

New French Anti-Gift Regime Finally Adopted for the Health Sector

At long last, the new French health care anti-gift regime, modified in 2017, should be applicable as of October 1, 2020, thanks to implementing regulations adopted over the summer. The French anti-gift regime, which...more

COVID-19 Key EU Developments, Policy & Regulatory Update No. 20

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion. ...more

Vital Signs: Digital Health Law Update | Summer 2020

Note From the Editors - With this Summer 2020 issue of Vital Signs, we take a moment to again applaud the remarkable actions of all the health care and life science organizations around the globe working tirelessly on our...more

JONES DAY PRESENTS® The Impact of Digital Health on Research and Clinical Trials [Video]

Digital health technologies have brought a number of significant breakthroughs to clinical trial programs, including faster patient recruitment, more efficient data collection, and better tracking of biometric information....more

155 Results
 / 
View per page
Page: of 7

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide